Soysa Niroshani S, Soysa Ishani B, Alles Neil
Department of Oral Medicine and Periodontology, Faculty of Dental Sciences, University of Peradeniya, Peradeniya, Sri Lanka.
School of Engineering and Advanced Technology, Massey University, Palmerston North, New Zealand.
J Investig Clin Dent. 2019 Aug;10(3):e12404. doi: 10.1111/jicd.12404. Epub 2019 Mar 18.
The aim of the present systematic review and meta-analysis was to address the following Population, Intervention, Comparison, and Outcome question: Is the efficacy of articaine better than lignocaine in adults requiring dental treatment? Four percent articaine was compared with 2% lignocaine for maxillary and mandibular infiltrations and block anesthesia, and with the principal outcome measures of anesthetic success. Using RevMan software, the weighted anesthesia success rates and 95% confidence intervals (CIs) were estimated and compared using a random-effects model. For combined studies, articaine was more likely to achieve successful anesthesia than lignocaine (N = 18, odds ratio [OR]: 1.92, 95% CI: 1.45-2.56, P < 0.00001, I = 32%). Maxillary and mandibular infiltration studies showed obvious superiority of articaine to lignocaine (N = 8, OR: 2.50, 95% CI: 1.51-4.15, P = 0.0004, I = 41%). Maxillary infiltration subgroup analysis showed no significant difference between articaine and lignocaine (N = 5, OR: 1.69, 95% CI: 0.88-3.23, P = 0.11, I = 19%). For combined mandibular anesthesia studies, articaine was superior to lignocaine (N = 14, OR: 1.99, 95% CI: 1.45-2.72, P < 0.0001, I = 32%), with further subgroup analysis showing significant differences in both mandibular block anesthesia (N = 11, OR: 1.55, 95% CI: 1.19-2.03, P = 0.001), I = 0%) and mandibular infiltration (N = 3, OR: 3.87, 95% CI: 2.62-5.72, P < 0.00001, I = 0%), indicating that articaine is more effective than lignocaine in providing anesthetic success in routine dental procedures.
本系统评价和荟萃分析的目的是解决以下关于人群、干预措施、对照和结局的问题:在需要牙科治疗的成人中,阿替卡因的疗效是否优于利多卡因?将4%阿替卡因与2%利多卡因用于上颌和下颌浸润麻醉及阻滞麻醉,并以麻醉成功率作为主要结局指标。使用RevMan软件,采用随机效应模型估计并比较加权麻醉成功率及95%置信区间(CI)。对于合并研究,阿替卡因比利多卡因更有可能实现成功麻醉(N = 18,比值比[OR]:1.92,95% CI:1.45 - 2.56,P < 0.00001,I² = 32%)。上颌和下颌浸润麻醉研究显示阿替卡因明显优于利多卡因(N = 8,OR:2.50,95% CI:1.51 - 4.15,P = 0.0004,I² = 41%)。上颌浸润亚组分析显示阿替卡因和利多卡因之间无显著差异(N = 5,OR:1.69,95% CI:0.88 - 3.23,P = 0.11,I² = 19%)。对于合并的下颌麻醉研究,阿替卡因优于利多卡因(N = 14,OR:1.99,95% CI:1.45 - 2.72,P < 0.0001,I² = 32%),进一步亚组分析显示在下颌阻滞麻醉(N = 11,OR:1.55,95% CI:1.19 - 2.03,P = 0.001,I² = 0%)和下颌浸润麻醉(N = 3,OR:3.87,95% CI:2.62 - 5.72,P < 0.00001,I² =